Buy & Sell BioNTech SE - ADR (BNTX) – BioNTech SE - ADR Price Today
Aura AI Summary
Key Stats
- $22.66BMarket Cap
- HealthSector
- -21.34%3M Drawdown
- $6.01BEnterprise Value
- -Dividend Yield
- 5% Buy | 95% SellTrading Activity
- 54 daysTypical Hold Time
BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $22.66B, with an enterprise value of $6.01B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -21.34%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 54 days, indicating typical investor behavior on the platform.
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Most Recent News
Law firm investigates fiduciary breaches at Badger Meter, Calix, New Era Energy, and Power Solutions.
Grabar Law Office is investigating claims against Badger Meter, Calix, New Era Energy & Digital, and Power Solutions International for alleged breaches of fiduciary duties by their officers and directors. The investigations stem from accusations of m...

Nominations open for 2026 Organic Grower of the Year Award at Organic Grower Summit
The Organic Grower Summit is accepting nominations for its ninth annual Grower of the Year Award, sponsored by John Deere. The award honors leaders advancing organic farming through innovation and sustainability, with four finalists chosen to attend ...

RAIN commits $200M to ecosystem, adds $100M liquidity, and preps for World Cup with Version 2 launch
RAIN, a decentralized prediction market on Arbitrum, announced a $200 million ecosystem commitment via Enlivex and added $100 million in liquidity to support growth. The protocol is preparing to launch Version 2 with features like permissionless mark...
